Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 9, 2025
ALPHAMIN ANNOUNCES DECISION TO RESUME MINING OPERATIONS
GlobeNewswire
·
April 9, 2025
GRAND BAIE, MAURITIUS, April 09, 2025 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX) (the “Company”) is pleased to announce that it is initiating a phased resumption of operations at the Company’s Bisie tin mine in Walikale District, …
Barbara Weber, M.D., Elected to ITM Supervisory Board
GlobeNewswire
·
April 9, 2025
Garching / Munich, Germany, April 09, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the election of Barbara Weber, M.D., to its Supervisory Board, effective May 01, 2025. The election …
VertiGIS Integrator optimiert Abfallwirtschaft bei IVAGO in Gent
GlobeNewswire
·
April 9, 2025
GIS-SAP-Synchronisation verbessert Betriebsabläufe und minimiert Datenredundanz Bonn, 9. April 2025 – VertiGIS, ein weltweit führender Anbieter von räumlichen Lösungen für das Asset Management, hat den VertiGIS Integrator bei der Interkommunalen …
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
GlobeNewswire
·
April 9, 2025
Phase 2 to evaluate safety, tolerability and efficacy of INNA-051 in the prevention of illness due to viral respiratory infections Study to be led by global health physician scientist, Dr. Justin Ortiz, Professor of Medicine at the University of Maryland …
Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development
GlobeNewswire
·
April 9, 2025
First-ever use of Ebenbuild’s Twinhale technology in idiopathic pulmonary fibrosis lung models Trial results published in Nature Communications Munich, Germany – April 9, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of …
XRP Bulls Rush to BlocScale Launchpad, as $BLOC Token Seed Sale Becomes the Hottest Opportunity on XRP Ledger
GlobeNewswire
·
April 9, 2025
LIJA, Malta, April 09, 2025 (GLOBE NEWSWIRE) -- The XRP Ledger is heating up as BlocScale Launchpad continues to make waves in the crypto space. In what industry observers are calling one of the most exciting developments in the XRP ecosystem, BlocScale’s …
Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer
GlobeNewswire
·
April 9, 2025
ZURICH, Switzerland, April 09, 2025 (GLOBE NEWSWIRE) -- Cytosurge AG, a leading biotech company in single-cell manipulation and cell engineering solutions, announces the appointment of Magid Haddouchi, PhD, as its new Chief Commercial Officer (CCO), …
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
GlobeNewswire
·
April 9, 2025
HELSINKI and NAPLES, Italy, April 09, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), an immunotherapy company developing novel, adaptable treatments for cancer, today announced the appointment of Marcella Origgi as its Chief Executive Officer (CEO …
MyEssayWriter.ai Integrates 'AI Suggest' to its Essay Writer, Revolutionizing Academic Writing
GlobeNewswire
·
April 9, 2025
LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- MyEssayWriter.ai introduces AI Suggest, the first feature in the industry to provide intelligent, personalized recommendations for essay topics, structures, and content, transforming the academic writing …
Management Increasing Ownership in Amaroq Minerals and RSU Vesting Update
GlobeNewswire
·
April 9, 2025
Reykjavík, April 09, 2025 (GLOBE NEWSWIRE) -- "Amaroq" or the "Company" Management increasing ownership in Amaroq Minerals And Vesting under the Restricted Share Unit Plan (the “RSU Plan”) and PDMR purchases TORONTO, ONTARIO – 09 April 2025 – Amaroq …
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
GlobeNewswire
·
April 9, 2025
– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in two poster presentations – – Additional poster presentation highlights new insights in genital …
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
GlobeNewswire
·
April 9, 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 New Clinical Data from Phase 2 Extension Period in Ulcerative Colitis on Long-Term Benefits and Safety of Anti-IL-7R mAb Lusvertikimab NANTES, France – …
OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la “Digestive Disease Week” (DDW) 2025
GlobeNewswire
·
April 9, 2025
OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la “Digestive Disease Week” (DDW) 2025 Présentation de nouvelles données cliniques sur les bénéfices et la sécurité à long terme de l’anticorps monoclonal …
Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
GlobeNewswire
·
April 9, 2025
Saint Herblain (France) and Schlieren (Zurich), April 9, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life- …
Valneva et LimmaTech annoncent la vaccination du premier participant à l’étude pédiatrique de Phase 2 du candidat vaccin tétravalent contre la shigellose S4V2
GlobeNewswire
·
April 9, 2025
Saint Herblain (France) et Schlieren (Zurich), le 9 avril 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, et LimmaTech Biologics AG, société de biotechnologies développant des vaccins pour la prévention de …
The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertension
GlobeNewswire
·
April 9, 2025
Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria in Black patients with confirmed resistant hypertension Allschwil, Switzerland – April 9, 2025 Idorsia Ltd (SIX …
US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement
GlobeNewswire
·
April 9, 2025
Allschwil, Switzerland – April 9, 2025 Idorsia Ltd (SIX: IDIA) today announced that the US Food …
Stallion Uranium Increases Private Placement to $1.45 Million
GlobeNewswire
·
April 9, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 09, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to …